119 related articles for article (PubMed ID: 7968139)
1. Eosinophil cationic protein in sputum from cystic fibrosis patients with Pseudomonas aeruginosa infections.
Reimert CM; Giwercman B; Høiby N; Kharazmi A
Lancet; 1994 Nov; 344(8935):1504-5. PubMed ID: 7968139
[No Abstract] [Full Text] [Related]
2. Major basic protein, but not eosinophil cationic protein or eosinophil protein X, is related to atopy in cystic fibrosis.
Koller DY; Halmerbauer G; Müller J; Frischer T; Schierl M
Allergy; 1999 Oct; 54(10):1094-9. PubMed ID: 10536888
[TBL] [Abstract][Full Text] [Related]
3. [Antibiotic inhalation in cystic fibrosis. A review of the literature].
Steinkamp G
Monatsschr Kinderheilkd; 1991 Feb; 139(2):73-80. PubMed ID: 1903843
[TBL] [Abstract][Full Text] [Related]
4. A more objective approach to the evaluation of antimicrobial therapy in cystic fibrosis.
Valletta EA; Rigo A; Bonazzi L; Zanolla L; Mastella G
Acta Univ Carol Med (Praha); 1990; 36(1-4):44-5. PubMed ID: 2130717
[TBL] [Abstract][Full Text] [Related]
5. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
[TBL] [Abstract][Full Text] [Related]
6. Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity.
Koller DY; Nething I; Otto J; Urbanek R; Eichler I
Am J Respir Crit Care Med; 1997 Mar; 155(3):1050-4. PubMed ID: 9116985
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil cationic protein concentration in saliva does not correlate with eosinophil cationic protein concentration in sputum.
Bowton DL; Seeds MC; Bass DA
Chest; 2003 Mar; 123(3 Suppl):372S. PubMed ID: 12628986
[No Abstract] [Full Text] [Related]
8. Eosinophilic activation in cystic fibrosis.
Koller DY; Götz M; Eichler I; Urbanek R
Thorax; 1994 May; 49(5):496-9. PubMed ID: 8016773
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa infection in cystic fibrosis. Occurrence of precipitating antibodies against pseudomonas aeruginosa in relation to the concentration of sixteen serum proteins and the clinical and radiographical status of the lungs.
Hoiby N; Jacobsen L; Jorgensen BA; Lykkegaard E; Weeke B
Acta Paediatr Scand; 1974 Nov; 63(6):843-8. PubMed ID: 4215280
[No Abstract] [Full Text] [Related]
10. Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.
Høiby N; Koch C
Thorax; 1990 Nov; 45(11):881-4. PubMed ID: 2256020
[No Abstract] [Full Text] [Related]
11. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
[TBL] [Abstract][Full Text] [Related]
12. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis.
Koller DY; Urbanek R; Götz M
Am J Respir Crit Care Med; 1995 Aug; 152(2):629-33. PubMed ID: 7633718
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of monitoring eosinophil activity in asthma.
Koller DY; Herouy Y; Götz M; Hagel E; Urbanek R; Eichler I
Arch Dis Child; 1995 Nov; 73(5):413-7. PubMed ID: 8554357
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis.
Vic P; Ategbo S; Turck D; Husson MO; Launay V; Loeuille GA; Sardet A; Deschildre A; Druon D; Arrouet-Lagande C
Arch Dis Child; 1998 Jun; 78(6):536-9. PubMed ID: 9713009
[TBL] [Abstract][Full Text] [Related]
15. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
[TBL] [Abstract][Full Text] [Related]
16. [Strategy of antibiotic therapy by various routes of administration in the initial colonization by Pseudomonas aeruginosa].
Châtain P
Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S105-12. PubMed ID: 12910142
[No Abstract] [Full Text] [Related]
17. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
[TBL] [Abstract][Full Text] [Related]
18. Administration of aerosolized antibiotics in cystic fibrosis patients.
Moss RB
Chest; 2001 Sep; 120(3 Suppl):107S-113S. PubMed ID: 11555564
[TBL] [Abstract][Full Text] [Related]
19. The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis.
Amin R; Lam M; Dupuis A; Ratjen F
Pediatr Pulmonol; 2011 Jun; 46(6):554-8. PubMed ID: 21337727
[TBL] [Abstract][Full Text] [Related]
20. Tobramycin therapy of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis: effect of dosage and concentration of antibiotic in sputum.
McCrae WM; Raeburn JA; Hanson EJ
J Infect Dis; 1976 Aug; 134 Suppl():S191-3. PubMed ID: 972281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
